Sular and Presbyopia - a phase IV clinical study of FDA data

Summary:

Presbyopia is reported as a side effect among people who take Sular (nisoldipine), especially for people who are female, 60+ old, also take Morphine Sulfate, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Presbyopia when taking Sular. It is created by eHealthMe based on reports of 1,710 people who have side effects when taking Sular from the FDA, and is updated regularly.

What is Sular?

Sular has active ingredients of nisoldipine. It is often used in high blood pressure. eHealthMe is studying from 1,757 Sular users. Check the latest studies of Sular.

What is Presbyopia?

Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close) is found to be associated with 313 drugs and 282 conditions by eHealthMe. Check the latest studies of Presbyopia.

On Aug, 07, 2026

1,710 people reported to have side effects when taking Sular.
Among them, 11 people (0.64%) have Presbyopia.

Among these 11 people:

What is the gender of people who have Presbyopia when taking Sular? *

female: 100 %
male: 0.0 %

What is the age of people who have Presbyopia when taking Sular? *

What are other drugs people take besides Sular? *

What are other side effects people have besides Presbyopia? *

Weight Loss: 11 people, 100.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 11 people, 100.00%
Gait Disturbance: 11 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 100.00%
Gingival Bleeding (bleeding gums): 11 people, 100.00%
Gingival Disorder (gum disease): 11 people, 100.00%
Gingival Oedema (swelling of gums): 11 people, 100.00%
Gingivitis (inflammation of gums): 11 people, 100.00%
Haematuria (presence of blood in urine): 11 people, 100.00%
Exostosis (formation of new bone on the surface of a bone): 11 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 100.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sular and have Presbyopia?

- Check whether Presbyopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sular:

Sular (1,757 reports)

Presbyopia treatments and more:

Presbyopia (1,265 reports)

Browse all side effects of Sular:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Presbyopia:

Presbyopia (313 drugs)

Browse all the conditions that are associated with Presbyopia:

Presbyopia (282 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nisoldipine (the active ingredients of Sular) and Sular (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.